Cargando…
Platelet-to-lymphocyte ratio as a predictive factor of complete pathologic response to neoadjuvant chemotherapy in breast cancer
Response to neoadjuvant chemotherapy in breast cancer patients is of prognostic value in determining short- and mid-term outcomes. Inflammatory biomarkers, such as platelet-to-lymphocyte ratio (PLR) and neutrophil to lymphocyte ratio (NLR), have been proposed as predictive factors of response to neo...
Autores principales: | Cuello-López, Javier, Fidalgo-Zapata, Ana, López-Agudelo, Laura, Vásquez-Trespalacios, Elsa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6235359/ https://www.ncbi.nlm.nih.gov/pubmed/30427884 http://dx.doi.org/10.1371/journal.pone.0207224 |
Ejemplares similares
-
Obesity and Prognostic Variables in Colombian Breast Cancer Patients: A Cross-Sectional Study
por: Cuello-López, Javier, et al.
Publicado: (2017) -
A nomogram based on platelet-to-lymphocyte ratio for predicting pathological complete response of breast cancer after neoadjuvant chemotherapy
por: Ma, Rulan, et al.
Publicado: (2023) -
Early changes of platelet‑lymphocyte ratio correlate with neoadjuvant chemotherapy response and predict pathological complete response in breast cancer
por: Dan, Jiaqiang, et al.
Publicado: (2023) -
Derived Neutrophil-to-Lymphocyte Ratio Predicts Pathological Complete Response to Neoadjuvant Chemotherapy in Breast Cancer
por: Ocaña, Alberto, et al.
Publicado: (2022) -
The Role of Neutrophil-lymphocyte Ratio and Platelet-lymphocyte Ratio in Predicting Neoadjuvant Chemotherapy Response in Breast Cancer
por: Kim, Hee Yeon, et al.
Publicado: (2019)